Exclusive

Publication

Byline

Location

US Patent Issued to Board of Regents, The University of Texas System on Aug. 25 for "Compounds with anti-tumor activity against cancer cells bearing HER2 exon 19 mutations" (Texas Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,708, issued on Aug. 25, was assigned to Board of Regents, The University of Texas System (Austin, Texas). "Compounds with anti-tumor activi... Read More


US Patent Issued to AIC246 on Aug. 25 for "Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl-3-[2-methoxy-5-(trifluoromethyl)phenyl-4H-quinazolin-4-ylacetate and sodium ions" (German, Spanish Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,709, issued on Aug. 25, was assigned to AIC246 AG & Co. KG (Wuppertal, Germany). "Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2... Read More


US Patent Issued to Recurium IP Holdings on Aug. 25 for "Combinations" (California, New Jersey Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,710, issued on Aug. 25, was assigned to Recurium IP Holdings LLC (San Diego). "Combinations" was invented by Ahmed Abdi Samatar (West Winds... Read More


US Patent Issued to SYNEURX INTERNATIONAL (TAIWAN) on Aug. 25 for "Salts of neuroceuticals and uses thereof" (Taiwanese, American Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,711, issued on Aug. 25, was assigned to SYNEURX INTERNATIONAL (TAIWAN) CORP.. "Salts of neuroceuticals and uses thereof" was invented by Gu... Read More


US Patent Issued to Eli Lilly and Co., Board of Regents, The University of Texas System on Aug. 25 for "Combination therapy with a mutant IDH inhibitor and a Bcl-2 inhibitor" (Indiana, Texas Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,712, issued on Aug. 25, was assigned to Eli Lilly and Co. (Indianapolis) and Board of Regents, The University of Texas System (Austin, Texas... Read More


US Patent Issued to Black Diamond Therapeutics on Aug. 25 for "Method of treating cancers with alkyne substituted quinazoline derivatives" (American, Swiss Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,713, issued on Aug. 25, was assigned to Black Diamond Therapeutics Inc. (Cambridge, Mass.). "Method of treating cancers with alkyne substit... Read More


US Patent Issued to Anaka Pharmaceuticals on Aug. 25 for "Combination therapy for treating executive function disorders" (Dominican Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,714, issued on Aug. 25, was assigned to Anaka Pharmaceuticals Inc. (Lexington, Mass.). "Combination therapy for treating executive function... Read More


US Patent Issued to SANTEN PHARMACEUTICAL, Boehringer Ingelheim International on Aug. 25 for "Agent for treating myopia, preventing myopia and/or suppressing myopia progression" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,715, issued on Aug. 25, was assigned to SANTEN PHARMACEUTICAL Co. LTD. (Osaka, Japan) and Boehringer Ingelheim International GmbH (Ingelheim... Read More


US Patent Issued to Children's Medical Center on Aug. 25 for "Compounds for inhibition of inflammation" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,716, issued on Aug. 25, was assigned to Children's Medical Center Corp. (Boston). "Compounds for inhibition of inflammation" was invented b... Read More


US Patent Issued on Aug. 25 for "3Alpha-OH-5Beta-pregnan-20-one compositions and methods for treating central nervous system disorders" (Utah Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,717, issued on Aug. 25. "3Alpha-OH-5Beta-pregnan-20-one compositions and methods for treating central nervous system disorders" was invente... Read More